Filter posts

MassBio Releases Statement Following Cost Trends Hearings

MassBio issues this statement, following the Massachusetts’ Health Policy Commission’s (HPC) hearing earlier this week on …

India Compulsory License: A Times of India Article Says It's Not Helping the Poor

India recently issued a compulsory license on Bayer’s liver and kidney cancer drug (Sorafenib) with …